Namikawa R, Suchi T, Ueda R, Itoh G, Koike K, Ota K, Takahashi T
Am J Pathol. 1987 May;127(2):279-87.
Biopsy specimens of lymph nodes with the histologic characteristics of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) were obtained from 9 cases (4 cases of AILD and 5 cases of AILD-like T lymphoma [AILD-T]) and histologically analyzed by the use of a double immunoenzymatic staining technique with the combination of a monoclonal antibody against lymphocyte membrane antigen and that against human DNA polymerase alpha (pol alpha), which is detectable in the nucleus of the cells in G1, S, and G2 phases. In all 9 cases, the pol alpha + proliferating cells had a peripheral T-cell phenotype with T11 and Leu-4 antigens, whereas proliferating B cells with B1 antigen were rarely observed. As for T-cell subset antigens, the proliferating T cells had T4+ helper/inducer phenotype in 7 cases, while T8+ suppressor/killer T cells proliferated in 2 cases, although a significant number of T4+ proliferating cells were also recognized. The study on malignant lymphomas that evolved in the 2 cases showed that the T-subset antigens on major proliferating tumor cells were the same as those found in the preceding AILD lesions, suggesting that lymphoma T cells originate from the AILD lesion. The results suggested that AILD without histologic manifestations of malignancy and AILD-T may be a neoplastic disease derived from either subset of peripheral T cells.
从9例患者(4例血管免疫母细胞性淋巴结病伴蛋白异常血症[AILD]和5例AILD样T淋巴瘤[AILD-T])获取具有AILD组织学特征的淋巴结活检标本,并采用双免疫酶染色技术进行组织学分析,该技术结合了针对淋巴细胞膜抗原的单克隆抗体和针对人DNA聚合酶α(polα)的单克隆抗体,polα在G1、S和G2期细胞的细胞核中可检测到。在所有9例病例中,polα+增殖细胞具有带有T11和Leu-4抗原的外周T细胞表型,而很少观察到带有B1抗原的增殖B细胞。至于T细胞亚群抗原,增殖的T细胞在7例中具有T4+辅助/诱导表型,而在2例中T8+抑制/杀伤T细胞增殖,尽管也识别出大量T4+增殖细胞。对2例演变而来的恶性淋巴瘤的研究表明,主要增殖肿瘤细胞上的T亚群抗原与先前AILD病变中发现的相同,提示淋巴瘤T细胞起源于AILD病变。结果提示,无恶性组织学表现的AILD和AILD-T可能是一种源自外周T细胞任一亚群的肿瘤性疾病。